Case-control study finds nocturia worsens depressive symptoms and quality of life in menopausal women, indicating need for assessment.
A BSTRACT Background: According to previous studies, urogenital symptoms, including nocturia, worsen with the menopause and depression and quality of life decrease in women experiencing nocturia. Objectives: This study aimed to determine the impact of nocturia on depressive symptoms and quality of life in menopausal women. Materials and Methods: This case–control study was conducted 110 premenopausal and 141 postmenopausal, who attended a Family Health Center in Ankara, Turkey, between July and September 2021. A total 251 menopausal women were included through convenience sampling. We utilized the World Health Organization Quality of Life Scale (WHOQOL-BREF), the Beck Depression Inventory (BDI), and the Sociodemographic Information Form. This study complies with the STROBE guideline. Results: In this study, the incidence of nocturia was higher in postmenopausal women (%69, 5) compared to premenopausal women (%49, 1). Except for the general health and physical health sub-dimension mean scores of the WHOQOL-BREF scale, other sub-dimension scores were statistically significantly lower in women with nocturia than in women without ( p < 0.05). The mean BDI scores were statistically significantly higher in women with nocturia ( p < 0.05). Conclusion: It was determined that nocturia negatively affects the quality of life and increases the depressive symptoms in menopausal women. Healthcare professionals should assess urologic symptoms and psychological symptoms, including depressive symptoms.
No takes yet. Share an insight, caveat, or question.
Şahin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: